Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer

Nature Genetics

Volumn 46, Issue 5, 2014, Pages 487-491

  Nik Zainal, Serena ^a,b   Wedge, David C ^a   Alexandrov, Ludmil B ^a   Petljak, Mia ^a   Butler, Adam P ^a   Bolli, Niccolo ^a,c   Davies, Helen R ^a   Knappskog, Stian ^d,e   Martin, Sancha ^a   Papaemmanuil, Elli ^a   Ramakrishna, Manasa ^a   Shlien, Adam ^a,f   Simonic, Ingrid ^g   Xue, Yali ^a   Tyler Smith, Chris ^a   Campbell, Peter J ^a,c   Stratton, Michael R ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF BERGEN   (Norway)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

^g CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3' UNTRANSLATED REGION; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLELE; APOBEC3A GENE; APOBEC3B GENE; ARTICLE; BLADDER CANCER; BLADDER CARCINOMA; BREAST CANCER; CANCER SUSCEPTIBILITY; CHROMOSOME 22; GENE; GENE DELETION; GENE NUMBER; GENETIC ASSOCIATION; GERMLINE MUTATION; HEAD AND NECK CANCER; HUMAN; HYBRID GENE; KIDNEY CANCER; LUNG ADENOCARCINOMA; MULTIPLE MYELOMA; PRIORITY JOURNAL; QUANTITATIVE TRAIT; RISK FACTOR; SOMATIC MUTATION; STOMACH ADENOCARCINOMA; THYROID CANCER; UTERINE CERVIX CANCER; UTERUS CANCER;

BREAST NEOPLASMS; CYTIDINE DEAMINASE; DNA COPY NUMBER VARIATIONS; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTAGENESIS; PROTEINS; SEQUENCE DELETION;

EID: 84899645475     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.2955     Document Type: Article

References (37)

1. Nik-Zainal, S. et al. Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979-993 (2012).
2. Nik-Zainal, S. et al. The life history of 21 breast cancers. Cell 149, 994-1007 (2012).
3. Stratton, M.R., Campbell, P.J. & Futreal, P.A. The cancer genome. Nature 458, 719-724 (2009).
4. Nowarski, R. & Kotler, M. APOBEC3 cytidine deaminases in double-strand DNA break repair and cancer promotion. Cancer Res. 73, 3494-3498 (2013).
5. Kidd, J.M., Newman, T.L., Tuzun, E., Kaul, R. & Eichler, E.E. Population stratification of a common APOBEC gene deletion polymorphism. PLoS Genet. 3, e63 (2007).
6. Craddock, N. et al. Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 464, 713-720 (2010).
7. Long, J. et al. A common deletion in the APOBEC3 genes and breast cancer risk. J. Natl. Cancer Inst. 105, 573-579 (2013).
8. Xuan, D. et al. APOBEC3 deletion polymorphism is associated with breast cancer risk among women of European ancestry. Carcinogenesis 34, 2240-2243 (2013).
9. Alexandrov, L.B. et al. Signatures of mutational processes in human cancer. Nature 500, 415-421 (2013).
10. Harris, R.S., Petersen-Mahrt, S.K. & Neuberger, M.S. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol. Cell 10, 1247-1253 (2002).
11. Conticello, S.G. The AID/APOBEC family of nucleic acid mutators. Genome Biol. 9, 229 (2008).
12. Longerich, S., Basu, U., Alt, F. & Storb, U. AID in somatic hypermutation and class switch recombination. Curr. Opin. Immunol. 18, 164-174 (2006).
13. Koito, A. & Ikeda, T. Intrinsic restriction activity by AID/APOBEC family of enzymes against the mobility of retroelements. Mob. Genet. Elements 1, 197-202 (2011).
14. Suspène, R. et al. Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism. Proc. Natl. Acad. Sci. USA 108, 4858-4863 (2011).
15. Petit, V., Vartanian, J.P. & Wain-Hobson, S. Powerful mutators lurking in the genome. Phil. Trans. R. Soc. Lond. B 364, 705-715 (2009).
16. Landry, S., Narvaiza, I., Linfesty, D.C. & Weitzman, M.D. APOBEC3A can activate the DNA damage response and cause cell-cycle arrest. EMBO Rep. 12, 444-450 (2011).
17. Suspène, R., Aynaud, M.M., Vartanian, J.P. & Wain-Hobson, S. Efficient deamination of 5-methylcytidine and 5-substituted cytidine residues in DNA by human APOBEC3A cytidine deaminase. PLoS ONE 8, e63461 (2013).
18. Alexandrov, L.B., Nik-Zainal, S., Wedge, D.C., Campbell, P.J. & Stratton, M.R. Deciphering signatures of mutational processes operative in human cancer. Cell Reports 3, 246-259 (2013).
19. Hodge, V.J. & Austin, J. A survey of outlier detection methodologies. Artif. Intell. Rev. 22, 85-126 (2004).
20. Nowarski, R. et al. APOBEC3G enhances lymphoma cell radioresistance by promoting cytidine deaminase-dependent DNA repair. Blood 120, 366-375 (2012).
21. Holtz, C.M., Sadler, H.A. & Mansky, L.M. APOBEC3G cytosine deamination hotspots are defined by both sequence context and single-stranded DNA secondary structure. Nucleic Acids Res. 41, 6139-6148 (2013).
22. Byeon, I.J. et al. NMR structure of human restriction factor APOBEC3A reveals substrate binding and enzyme specificity. Nat. Commun. 4, 1890 (2013).
23. Petit, V. et al. Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo. J. Mol. Biol. 385, 65-78 (2009).
24. Beale, R.C. et al. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo. J. Mol. Biol. 337, 585-596 (2004).
25. Taylor, B.J. et al. DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis. Elife 2, e00534 (2013).
26. Shinohara, M. et al. APOBEC3B can impair genomic stability by inducing base substitutions in genomic DNA in human cells. Sci. Rep. 2, 806 (2012).
27. Burns, M.B. et al. APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 494, 366-370 (2013).
28. Burns, M.B., Temiz, N.A. & Harris, R.S. Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat. Genet. 45, 977-983 (2013).
29. Roberts, S.A. et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat. Genet. 45, 970-976 (2013).
30. Rousseeuw, P.J., Ruts, I. & Tukey, J.W. The bagplot: a bivariate boxplot. Am. Stat. 53, 382-387 (1999).
31. 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature 467, 1061-1073 (2010).
32. Li, J.Z. et al. Worldwide human relationships inferred from genome-wide patterns of variation. Science 319, 1100-1104 (2008).
33. Perry, G.H. et al. Evolutionary genetics of the human Rh blood group system. Hum. Genet. 131, 1205-1216 (2012).
34. Xue, Y. et al. Population differentiation as an indicator of recent positive selection in humans: an empirical evaluation. Genetics 183, 1065-1077 (2009).
35. Pickrell, J.K. et al. Signals of recent positive selection in a worldwide sample of human populations. Genome Res. 19, 826-837 (2009).
36. Nielsen, R. et al. Genome scans for selective sweeps using SNP data. Genome Res. 15, 1566-1575 (2005).
37. 1000 Genomes Project Consortium. An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56-65 (2012).